Additional Issues. Within [**] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issues.
Appears in 10 contracts
Sources: Collaboration and License Agreement (Epizyme, Inc.), Collaboration and License Agreement, License Agreement (Beam Therapeutics Inc.)
Additional Issues. Within [**] days twenty (20) Business Days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 8 contracts
Sources: Collaboration and License Agreement (Forma Therapeutics Holdings, Inc.,), License Agreement (Aptalis Pharma Inc), Development Agreement (Aptalis Pharma Inc)
Additional Issues. Within [**] ten (10) days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 7 contracts
Sources: Collaboration Agreement (Akebia Therapeutics, Inc.), Manufacturing & Services Agreement (Myovant Sciences Ltd.), Collaboration Agreement (Akebia Therapeutics, Inc.)
Additional Issues. Within [**] days [ ]* after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 7 contracts
Sources: License Agreement (Rhythm Pharmaceuticals, Inc.), License Agreement (Rhythm Pharmaceuticals, Inc.), License Agreement (Rhythm Pharmaceuticals, Inc.)
Additional Issues. Within [**] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 4 contracts
Sources: License Agreement (MEI Pharma, Inc.), License Agreement (Infinity Pharmaceuticals, Inc.), Collaboration and License Agreement (Eleven Biotherapeutics, Inc.)
Additional Issues. Within [**] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 4 contracts
Sources: License Agreement (Akebia Therapeutics, Inc.), License Agreement (Akebia Therapeutics, Inc.), License and Collaboration Agreement (Lexicon Pharmaceuticals, Inc.)
Additional Issues. Within [**] days * *** after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 3 contracts
Sources: Option for a License Agreement, Option for a License Agreement (Macrogenics Inc), Option for a License Agreement (Macrogenics Inc)
Additional Issues. Within [****] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 3 contracts
Sources: Collaboration Agreement (Biotech Spinco, Inc.), Collaboration Agreement (Facet Biotech Corp), Collaboration Agreement (Protein Design Labs Inc/De)
Additional Issues. Within [**] *]days after the receipt of the an Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: License Agreement (Sol-Gel Technologies Ltd.), License Agreement (Sol-Gel Technologies Ltd.)
Additional Issues. Within [***] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Akebia Therapeutics, Inc.), Collaboration Agreement (Seattle Genetics Inc /Wa)
Additional Issues. Within [**[ * ] business days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP), Collaboration and Promotion Agreement (Aspreva Pharmaceuticals CORP)
Additional Issues. Within [**[ * ] days Business Days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: Research and Development Collaboration and License Agreement (Dynavax Technologies Corp), Research and Development Collaboration and License Agreement (Dynavax Technologies Corp)
Additional Issues. Within [*] ([*] ]) business days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: License Agreement (Radius Health, Inc.), License Agreement (Radius Health, Inc.)
Additional Issues. Within [**] days after the receipt of the an Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 2 contracts
Sources: License Agreement (La Jolla Pharmaceutical Co), License Agreement (Tetraphase Pharmaceuticals Inc)
Additional Issues. Within [**] thirty (30) days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issues.
Appears in 1 contract
Sources: Collaboration, Option and License Agreement (Zogenix, Inc.)
Additional Issues. Within [***] days Business Days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 1 contract
Sources: Collaboration and License Agreement (Rexahn Pharmaceuticals, Inc.)
Additional Issues. Within [***] ([***]) days after the receipt of the an Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesresolution.
Appears in 1 contract
Sources: License and Collaboration Agreement (Frequency Therapeutics, Inc.)
Additional Issues. Within [**] * (***) business days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issuesto be resolved.
Appears in 1 contract
Sources: Development and License Agreement (Biocryst Pharmaceuticals Inc)